Literature DB >> 16457633

Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures.

Ahmed Kamal1, K Laxma Reddy, V Devaiah, N Shankaraiah, M V Rao.   

Abstract

Quinoxaline, quinazoline and benzimidazole based templates have been synthesized on solid-support employing different methodologies. This review enlightens academic and industrial examples of combinatorial synthesis for this type of heterocycles that appeared in the literature in the last decade. Hence, some of the important synthetic strategies for the generation of quinoxaline, quinazoline and benzimidazole based privileged structures, and the important biological activities for these heterocycles have been highlighted. Further, benzothiadiazinone, thioxoquinazolinone, cinnoline and indazole are also examined in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457633     DOI: 10.2174/138955706775197839

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  9 in total

1.  Synthesis of quinazolines from N-(2-nitrophenylsulfonyl)iminodiacetate and alpha-(2-nitrophenylsulfonyl)amino ketones via 2H-indazole 1-oxides.

Authors:  Sona Krupková; Greg A Slough; Viktor Krchnák
Journal:  J Org Chem       Date:  2010-07-02       Impact factor: 4.354

2.  Synthesis and biological evaluation of analogues of AKT (protein kinase B) inhibitor-IV.

Authors:  Qi Sun; Runzhi Wu; Sutang Cai; Yuan Lin; Llewlyn Sellers; Kaori Sakamoto; Biao He; Blake R Peterson
Journal:  J Med Chem       Date:  2011-02-14       Impact factor: 7.446

3.  Facile Preparation of 4-Substituted Quinazoline Derivatives.

Authors:  Daniel Z Wang; Lesong Yan; Lingmei Ma
Journal:  J Vis Exp       Date:  2016-02-15       Impact factor: 1.355

4.  1-Isopropyl-4-nitro-6-meth-oxy-1H-benzimidazole.

Authors:  Michael D Moore; Prashi Jain; Patrick T Flaherty; Peter L D Wildfong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-25

5.  An effective microwave-induced iodine-catalyzed method for the synthesis of quinoxalines via condensation of 1,2-diamines with 1,2-dicarbonyl compounds.

Authors:  Debasish Bandyopadhyay; Sanghamitra Mukherjee; Robert R Rodriguez; Bimal K Banik
Journal:  Molecules       Date:  2010-06-09       Impact factor: 4.411

6.  Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-N-(2-aryl-1H-benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors.

Authors:  Daseul Im; Hyungwoo Moon; Jingwoong Kim; Youri Oh; Miyoung Jang; Jung-Mi Hah
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

7.  Discovery of 5-methyl-N-(2-arylquinazolin-7-yl)isoxazole-4-carboxamide analogues as highly selective FLT3 inhibitors.

Authors:  Daseul Im; Hyungwoo Moon; Jinwoong Kim; Youri Oh; Miyoung Jang; Jung-Mi Hah
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

8.  A High-Throughput Screening Method for Determining the Optimized Synthesis Conditions of Quinoxaline Derivatives Using Microdroplet Reaction.

Authors:  Yanmei Yang; Junmin Liu; Zhenzhen Chen; Weihua Niu; Ran Li; Le Niu; Peng Yang; Xiaoyan Mu; Bo Tang
Journal:  Front Chem       Date:  2020-09-10       Impact factor: 5.221

9.  Rational design and synthesis of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants.

Authors:  Daseul Im; Joonhong Jun; Jihyun Baek; Haejin Kim; Dahyun Kang; Hyunah Bae; Hyunwook Cho; Jung-Mi Hah
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.